Intellipharmaceutics Says Final FDA Approval has Not Yet been Issued for 5 MG Strength of Generic Dexmethylphenidate Generic of Focalin XR

By: via Benzinga
Intellipharmaceutics (NASDAQ: IPCI) advised that a final FDA approval has not yet been issued to the Company for the 5 mg strength of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.